| Symbol | AGPU |
|---|---|
| Name | PREDICTIVE ONCOLOGY INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 91 43RD STREET,SUITE 110, PITTSBURGH, Pennsylvania, 15201, United States |
| Telephone | +1 412 432-1500 |
| Fax | — |
| — | |
| Website | https://www.predictive-oncology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001446159 |
| Description | Predictive Oncology Inc. is a science-driven company focused on applying its proprietary artificial intelligence to accelerate oncologic drug discovery and enable drug development. Predictive Oncology uses AI and its proprietary biobank of more than 150,000 tumor samples, categorized by tumor type, to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. The Company also creates and develops tumor-specific 3D cell culture models mimicking the physiological environment of human tissue, enabling better-informed decision-making during drug development. Predictive Oncologys suite of solutions supports oncology drug development from early discovery to clinical trials. Additional info from NASDAQ: |
Axe Compute Receives $317 Million in Customer Prepayments Under Global AI Infrastructure Contracts
Read more(99% Neutral) PREDICTIVE ONCOLOGY INC. (AGPU) Announces Business Combination
Read moreAxe Compute and Duos Technologies Enter into Agreements For 55 MW of New AI Data Center Capacity Across Multiple U.S. Locations
Read more(30% Negative) PREDICTIVE ONCOLOGY INC. (AGPU) Reports Q3 2026 Financial Results
Read moreAxe Compute Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
Read moreNew Form EFFECT - Axe Compute Inc. <b>Filed:</b> 2026-07-27 <b>AccNo:</b> 9999999995-26-002459 <b>Size:</b> 2 KB
Read more(86% Neutral) PREDICTIVE ONCOLOGY INC. (AGPU) Reports Q3 2026 Financial Results
Read moreAxe Compute Secures $1.5 Billion Five-Year Dedicated AI Infrastructure Contract, Surpassing $3 Billion in 2026 Signed Contracted Value
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Rese… | — | Cancer, All Types | Unknown | 2019-03-21 | 2024-03-12 | ClinicalTrials.gov |